Catalyst Wire Dossier Catalyst Wire Dossier

9-Aminocamptothecin

9-aminocamptothecin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 9-Aminocamptothecin, covering 2008-03-04 to 2008-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin [Phase 2]

See pricing